94 related articles for article (PubMed ID: 7758413)
1. [Current advances in HIV pathogenesis. Results of therapy and vaccine development].
Wagner R; Mayer J; Wolf H
Dtsch Med Wochenschr; 1995 May; 120(20):728-36. PubMed ID: 7758413
[No Abstract] [Full Text] [Related]
2. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
3. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
Vieillard V; Costagliola D; Simon A; Debré P;
AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
[TBL] [Abstract][Full Text] [Related]
4. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
[TBL] [Abstract][Full Text] [Related]
6. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
7. [Possible pathogenic role of IL-16 on SLE: with reference to HIV-1 infection].
Lee S; Sekigawa I
Ryumachi; 1998 Oct; 38(5):747-51. PubMed ID: 9852753
[No Abstract] [Full Text] [Related]
8. In vitro selection of HIV and CMV specific T-lymphocytes.
Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
[TBL] [Abstract][Full Text] [Related]
9. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120.
Höhn H; Kortsik C; Tully G; Nilges K; Necker A; Freitag K; Neukirch C; Galle P; Löhr H; Maeurer MJ
Eur J Immunol; 2003 Jun; 33(6):1613-23. PubMed ID: 12778479
[TBL] [Abstract][Full Text] [Related]
11. HIV: Bad news for stop--start therapy?
McMichael AJ; Rowland-Jones SL
Nature; 2002 Nov; 420(6914):371, 373. PubMed ID: 12459769
[No Abstract] [Full Text] [Related]
12. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
13. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
14. An anti-idiotype vaccine for AIDS based on the HIV receptor.
Dalgleish AG
Ann Ist Super Sanita; 1991; 27(1):27-31. PubMed ID: 1683525
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
Westendorp MO; Frank R; Ochsenbauer C; Stricker K; Dhein J; Walczak H; Debatin KM; Krammer PH
Nature; 1995 Jun; 375(6531):497-500. PubMed ID: 7539892
[TBL] [Abstract][Full Text] [Related]
16. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
17. Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients.
Chams V; Idziorek T; Klatzmann D
AIDS; 1991 May; 5(5):565-9. PubMed ID: 1677809
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
Lekutis C; Shiver JW; Liu MA; Letvin NL
J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
[TBL] [Abstract][Full Text] [Related]
19. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
20. AIDS and immune dysfunction. Alternative etiologic mechanisms.
del Guercio P
Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
